Serum & Bharat Biotech can do intranasal vaccine trials in India after approval Says Dr. Harsh Vardhan

Bharat Biotech and Serum India may pursue clinical trials in India of intranasal vaccine on Covid-19 after receiving approval from the regulatory authority in the coming months. During Sunday Samvaad-16 Union Health Minister Dr. Harsh Vardhan said “There are no intranasal COVID-19 vaccines in India at the moment, Serum India and Bharat Biotech are expected to pursue clinical trials of such vaccines in India in the coming months on receipt of regulatory approval.

Recommended For You